International Journal of Trichology

: 2022  |  Volume : 14  |  Issue : 2  |  Page : 60--61

Treatment of resistant alopecia areata with tofacitinib

Ganesh Avhad 
 Skin and Hair World, Mumbai, Maharashtra, India

Correspondence Address:
Ganesh Avhad
Skin and Hair World, M3, Shivam Building, Above Wellness Forever Chemist, Opp. PVR Cinema, Sion Circle, Mumbai - 400 022, Maharashtra

The activity of tofacitinib for Alopecia areata (AA) has been reported but mainly from the western countries. We report the case of a young female Indian patient with AA unresponsive to therapy. Improvements in terms of hair regrowth were observed within 2 months of treatment with oral tofacitinib 5 mg BID tablets. The effectiveness of tofacitinib in hair regrowth was maintained till 5-month follow-up period. There were no side effects reported and the treatment with tofacitinib was well-tolerated.

How to cite this article:
Avhad G. Treatment of resistant alopecia areata with tofacitinib.Int J Trichol 2022;14:60-61

How to cite this URL:
Avhad G. Treatment of resistant alopecia areata with tofacitinib. Int J Trichol [serial online] 2022 [cited 2022 Jun 30 ];14:60-61
Available from:;year=2022;volume=14;issue=2;spage=60;epage=61;aulast=Avhad;type=0